跳至主要内容
临床试验/JPRN-UMIN000014223
JPRN-UMIN000014223招募中未知

The clinical study to explore the effects of sodium-dependent glucose co-transporter 2 inhibitors on responses of orexigenic hormone 'ghrelin' in patients with type 2 diabetes - Effects of SGLT2 inhibitors on ghrelin secretion in patients with type 2 diabetes

Wakayama medical university, the first department of medicine0 个研究点目标入组 60 人开始时间: 2014年6月16日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 75years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)Body Mass Index <22 2)an excessive alcohol drunker 3)patients who were added same drugs during the course of the trial 4)patients with severe ketosis, diabetic coma or precoma 5)patients with hepatic dysfunction(child-pugh B or worse) or severe renal dysfunction(eGFR<50) 6)patients with severe infection, perioperative period or severe injury 7)patients with allergy for SGLT2 inhibitors 8)patients with a history of gastrointestinal tract surgery 9)pregnant women or women that may have become pregnant 10)patients determined to be inappropriate by physician

研究者

发起方
Wakayama medical university, the first department of medicine

相似试验